Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial.
Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial.
J. Alexander,H. Reynolds,4 Authors,J. Hochman
2007 · DOI: 10.1001/JAMA.297.15.JOC70035
377 Citations
TLDR
Tilarginine, 1-mg/kg bolus and 5-hour infusion, did not reduce mortality rates in patients with refractory cardiogenic shock complicating acute myocardial infarction despite establishment of an open infarct artery.